Effect of concomitant use of formula diet with dapagliflozin on body compositions, metabolic improvement, and its safety in type 2 diabetes mellitus.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 18 Jul 2018
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Diet-Dapper study
- 09 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 21 Mar 2017 Status changed from not yet recruiting to recruiting.
- 03 Mar 2017 New trial record